Elizabeth A. Garofalo, Director at ACADIA PHARMACEUTICALS INC (ACAD), sold 9,838 shares at $18.23 ($179K) on 2025-03-05, disclosed to the SEC on 2025-03-06.
Open-market sale of $179k ACAD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.23 | 4,919 | $90K | 50.0% |
| 2 | $18.23 | 4,919 | $90K | 50.0% |
| Total | $18.23 avg | 9,838 | $179K | 100% |
| Filing → |